对于BPH手术决策的AI:成本效益和结果
John Lama1, Joshua Winograd1, Alia Codelia-Anjum2
1Weill Cornell Medical College, New York City, NY, USA.
Current urology reports
|September 23, 2024
概括
人工智能 (AI) 通过使用先进的成像和预测模型来提高诊断准确性,提高良性前列腺增生症 (BPH) 管理. 人工智能在个性化治疗和降低BPH患者的医疗费用方面显示出潜力.
科学领域:
- 泌尿器科 泌尿器科 泌尿器科 泌尿器科
- 医疗成像医学成像
- 人工智能的人工智能
背景情况:
- 良性前列腺增生 (BPH) 影响近70%的60岁以上的男性,由于各种症状和治疗反应,临床挑战.
- 根据美国泌尿病学协会的指导方针,在医学治疗失败后考虑对BPH进行手术干预.
研究的目的:
- 审查人工智能 (AI) 在改善良性前列腺增生症 (BPH) 管理决策中的作用.
- 探索AI在诊断,预测结果和优化BPH治疗中的应用.
主要方法:
- 使用人工智能对非侵入性成像方式 (多参数核磁共振,超声) 的分析.
- 开发整合血清生物标志物和组织病理学的人工智能模型.
- 利用人工智能预测患者的结果和优化治疗策略.
主要成果:
- 人工智能提高了BPH的诊断精度,并高精度地将其与前列腺癌 (PC) 区分开来.
- 人工智能模型提高了诊断准确性,可能减少了对侵入性手术的需求.
- 人工智能通过预测治疗后的结果和优化治疗来帮助个性化医疗.
结论:
- 人工智能在简化BPH管理和改善患者结果方面显示出显著的潜力.
- 人工智能应用可以帮助降低与BPH相关的医疗保健成本.
- 进一步的研究和开发对于将人工智能集成到临床工作流程和为BPH管理建立标准化评估指标至关重要.
相关概念视频
Psychosurgery
47
Psychosurgery, the surgical alteration or permanent removal of brain tissue to alleviate severe psychological conditions, stands as one of the most radical and controversial treatments in the history of mental health care. Its development and application have evolved significantly, marked by dramatic shifts in scientific understanding and ethical perspectives.
Historical Development of Psychosurgery
In the 1930s, Portuguese neurologist Antonio Egas Moniz introduced a surgical procedure designed...
Historical Development of Psychosurgery
In the 1930s, Portuguese neurologist Antonio Egas Moniz introduced a surgical procedure designed...
47
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
124
Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
124
Treatment for Pulmonary Arterial Hypertension: Receptor Tyrosine Kinase Inhibitors and Calcium Channel Blockers
146
Receptor tyrosine kinase inhibitors (TKIs) and calcium channel blockers (CCBs) are two critical categories of drugs employed in the treatment of pulmonary artery hypertension (PAH). PAH is a disease that causes high blood pressure in the pulmonary arteries, resulting in chest pain, fatigue, and shortness of breath.
TKIs, such as imatinib (Gleevec), are particularly effective in tackling the growth and mitogenic factors that become upregulated in PAH patients. These factors contribute to the...
TKIs, such as imatinib (Gleevec), are particularly effective in tackling the growth and mitogenic factors that become upregulated in PAH patients. These factors contribute to the...
146
Chronic Pancreatitis II: Collaborative Care
70
The management of chronic pancreatitis is multifaceted, involving a comprehensive approach that includes thorough assessment, diagnostic testing, and a variety of management strategies.
Assessment:
Assessment:
70


